These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. N Engl J Med; 1996 Aug 08; 335(6):377-83. PubMed ID: 8676931 [Abstract] [Full Text] [Related]
7. [Value of the bacteriological study of the associated bacterial flora of the sputum of patients with chronic pulmonary tuberculosis]. Boccitto G, Salvati F, De Ritis G. Policlinico Prat; 1970 Apr 13; 77(15):477-89. PubMed ID: 4987995 [No Abstract] [Full Text] [Related]
8. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. Mitchison DA. Soc Appl Bacteriol Symp Ser; 1996 Apr 13; 25():72S-80S. PubMed ID: 8972122 [No Abstract] [Full Text] [Related]
9. Antimycobacterial therapy for Crohn's disease: a reanalysis. Behr MA, Hanley J. Lancet Infect Dis; 2008 Jun 13; 8(6):344. PubMed ID: 18501846 [No Abstract] [Full Text] [Related]
10. [A controlled clinical trial of long course chemotherapy regimens containing rifabutin in the treatment of multi-drug resistant pulmonary tuberculosis]. Zhu LZ, Fu Y, Chu NH, Ye ZZ, Xiao HP, Wang W, Yuan SL, Zhang X, Luo YA, Ma LP. Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug 13; 29(8):520-3. PubMed ID: 17074263 [Abstract] [Full Text] [Related]
11. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council. Tuber Lung Dis; 1992 Feb 13; 73(1):59-67. PubMed ID: 1326349 [Abstract] [Full Text] [Related]
13. [Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis]. Khomenko AG, Kozulitsyna TI, Kaminskaia AA, Andrusskaia MK, Khlopovskiĭ SG. Probl Tuberk; 1981 Jun 13; (6):17-22. PubMed ID: 7024984 [No Abstract] [Full Text] [Related]